SANOFI PASTEUR

'Sanofi pasteur' is the vaccines business of sanofi-aventis Group. It is the largest company in the world devoted entirely to vaccines.

Contents

History

Key Dates

Key facts & figures in 2004

Vaccines

History

In 2004, Aventis merged with and into Sanofi. The new sanofi-aventis Group became the world's 3rd largest pharmaceutical company. Aventis Pasteur, the vaccine division of sanofi-aventis Group, changes its name to sanofi pasteur.

Key Dates

★ 1897, Marcel Mérieux creates the Mérieux Biological Institute in Lyon. Richard Slee creates the Pocono Biological Laboratories, in Swiftwater (Pennsylvania) in the US

★ 1914, John FitzGerald creates Connaught Laboratories, part of the University of Toronto.

★ 1968, Rhône-Poulenc acquires 51% of the capital of the Institut Mérieux.

★ 1974, Pasteur Institute creates Pasteur Production, a subsidiary specializing in manufacturing vaccines

★ 1978, Connaught Laboratories in Canada acquires the vaccine manufacturing facility (Merrell-National Laboratories) at Swiftwater, Pennsylvania, US.

★ 1985, Pasteur Production, the vaccines branch of the Institut Pasteur, is acquired by the Mérieux Institute, and Pasteur Vaccins is created

★ 1989, The Mérieux Institute acquires the Connaught Laboratories in Canada and its subsidiaries and becomes a world leader in human biology

★ 1990, Creation of Pasteur Mérieux Serums & Vaccins

★ 1994, Pasteur Mérieux Sérums & Vaccins becomes a wholly owned subsidiary of Rhône-Poulenc.

★ 1996, Pasteur Mérieux Connaught is the new name of Pasteur Mérieux Serums et Vaccins

★ 1999, Rhône-Poulenc and Hoechst unite their Life Sciences activities in a single company, which takes on the name Aventis. Within this group, Pasteur Mérieux Connaught changes its name to Aventis Pasteur.

★ 2004, merger of Aventis with and into Sanofi. The new sanofi-aventis Group becomes the world's 3rd largest pharmaceutical company, behind Pfizer and GlaxoSmithKline. Aventis Pasteur, the vaccine division of the sanofi-aventis Group, changes its name to sanofi pasteur.

Key facts & figures in 2004

★ Sanofi pasteur - proforma sales: € 1.624 billion (growth of 7.5%)

★ Staff: over 9,000 employees

★ Nearly a billion doses of vaccines sold to protect over 500 million people in the world

★ A wide range of vaccines protecting against 20 bacterial and viral diseases

★ A presence in 150 countries

★ R&D: 17% of sales reinvested in R&D, over 1,000 persons working in France, U.S.A. and Canada

★ Headquarters: Lyon, France

Vaccines

★ TheraCys®, Bladder Cancer

★ ADACEL™, Diphtheria, Tetanus and Pertussis

★ DAPTACEL® (DTaP), Diphtheria, Tetanus and Pertussis

★ Diphtheria and Tetanus Toxoids Adsorbed USP , Diphtheria, Tetanus and Pertussis

★ Tetanus Toxoid Adsorbed, Diphtheria, Tetanus and Pertussis

★ TriHIBit®, Diphtheria, Tetanus and Pertussis and Haemophilus influenzae type b

★ Tripedia®, Diphtheria, Tetanus, Pertussis

★ ActHIB®, Haemophilus influenzae type b

★ Fluzone®, Influenza Virus Vaccine]], Influenza

★ Menactra®, Meningococcal A/C/Y/W-135 Conjugate Vaccine

★ Menomune®-A/C/Y/W-135, Meningococcal Vaccine

★ IPOL®, Polio

★ Imogam® Rabies-HT Immune Globulin, Rabies

★ IMOVAX® RABIES, Rabies

★ DECAVAC®, Tetanus and Diphtheria

★ Tetanus Toxoid For Booster Use Only, Tetanus

★ JE-VAX®, Japanese Encephalitis Virus Vaccine

★ Typhim Vi®, Typhoid Vi Polysaccharide Vaccine

★ YF-VAX®, Yellow Fever Vaccine

★ Tubersol®, Tubercolosis